12 Apr 2013

Energising Biopharma in Europe: Collaboration breeds innovation

By Titta Rosvall-Puplett, EBE Executive Director (Source: New European Economy - April 2013) Europe has supported the birth of the healthcare biotechnology industry. It provides significant value to medical innovation, public health and the economy, and more than 325 million patients have so far benefited from biotech medicines....

Read more
01 Dec 2012

“How to strengthen the biopharma ecosystem” : Commentary by EBE President, Dr Roberto Gradnik

By Roberto Gradnik, President of EBE and CEO of Stallergenes (Source: MedNous November/December 2013) The sustainability of the biopharmapharmaceutical sector depends on a continual flow of new startups to both feed Big Pharma's pipelines and to create the next generation of emerging mid-cap companies....

Read more
1 7 8 9